Profen and Cotellic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Profen (ibuprofen) and Cotellic (cobimetinib fumarate). Common drug interactions include rash among females and haemorrhage urinary tract among males.

The phase IV clinical study analyzes what interactions people have when they take Profen and Cotellic. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.

What is Cotellic?

Cotellic has active ingredients of cobimetinib fumarate. eHealthMe is studying from 1,908 Cotellic users. Check the latest studies of Cotellic.



On Jul, 07, 2026

18 people who take Profen and Cotellic together, and have interactions are studied.

Profen and Cotellic drug interactions.

What are the common drug interactions of Profen and Cotellic, by gender? *:

female:

  1. Rash
  2. Acne (skin problems that cause pimples)
  3. Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
  4. Fatigue (feeling of tiredness)
  5. Nausea (feeling of having an urge to vomit)
  6. Pyrexia (fever)
  7. Conjunctivitis (pink eye)
  8. Eye swelling
  9. Lip swelling
  10. Onychoclasis (breaking of the nails)

male:

  1. Haemorrhage urinary tract (bleeding from uterine)
  2. Abasia (inability to walk)
  3. Anger
  4. Angioedema (rapid swelling of the dermis)
  5. Cardiac disorder
  6. Rash generalised (rash on most of body parts)
  7. Swelling face

What are the common drug interactions of Profen and Cotellic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Angioedema (rapid swelling of the dermis)
  2. Swelling face

50-59:

  1. Abasia (inability to walk)
  2. Abdominal pain
  3. Anger
  4. Aphasia (damage to the parts of the brain that control language)
  5. Asthenia (weakness)
  6. Blood creatine phosphokinase increased
  7. Cardiac disorder
  8. Decreased appetite
  9. Diarrhoea
  10. Disorientation (disability in which the senses of time, direction, and recognition of people and places)

60+:

  1. Diarrhoea
  2. Rash
  3. Nausea (feeling of having an urge to vomit)
  4. Onychoclasis (breaking of the nails)
  5. Oral candidiasis (fungal infection of mouth)
  6. Peripheral swelling
  7. Pneumonia
  8. Pyrexia (fever)
  9. Swollen tongue (swelling of tongue)
  10. Dry mouth

What are the existing conditions these people have? *

  1. Malignant Melanoma (skin cancer rises from melancytes): 8 people, 44.44%
  2. Metastases To Lymph Nodes (cancer spreads to lymph node): 7 people, 38.89%
  3. Abscess (pus): 7 people, 38.89%
  4. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 6 people, 33.33%
  5. Ovarian Cancer (cancer of ovary): 3 people, 16.67%
  6. Vitamin B12 Deficiency: 2 people, 11.11%
  7. High Blood Cholesterol: 2 people, 11.11%
  8. Fever: 2 people, 11.11%
  9. Skin Cancer: 1 person, 5.56%
  10. Abdominal Pain Upper: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Profen and Cotellic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Profen and Cotellic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cotellic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cotellic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen and cobimetinib fumarate (the active ingredients of Profen and Cotellic, respectively), and Profen and Cotellic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: